Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Roya Sarkhosh-Inanlou"'
Autor:
Ali Golchin, Forough Shams, Arefeh Basiri, Parviz Ranjbarvan, Samaneh Kiani, Roya Sarkhosh-Inanlou, Abdolreza Ardeshirylajimi, Shiva Gholizadeh-Ghaleh Aziz, Sanaz Sadigh, Yousef Rasmi
Publikováno v:
Stem Cell Reviews and Reports. 18:1892-1911
Wound healing is a serious obstacle due to the complexity of evaluation and management. While novel approaches to promoting chronic wound healing are of critical interest at the moment, several studies have demonstrated that combination therapy is cr
Autor:
Vali, Abdoli, Roya, Sarkhosh-Inanlou, Nowruz, Delirezh, Safiyeh, Aghazadeh, Nima, Shaykh-Baygloo, Mehdi, Imani
Publikováno v:
Veterinary research forum : an international quarterly journal. 12(4)
Chronic myelogenous leukemia (CML) is one of prevalent cancer worldwide. In spite of various designed drugs, chemoresistance remains the main obstacle in cancer cure. Therefore, developing novel strategy for treatment of CML is an urgent need. Fragac
Publikováno v:
Chemical biologydrug designREFERENCES. 95(2)
Ovarian cancer is considered as one of the most lethal gynecological cancers, and cisplatin-based therapy has an important role as the first-line option for chemotherapy. Resistance to chemotherapy is the main obstacle against successful cancer chemo
Autor:
Jafar Soleymani, Bashir Adel, Jafar Ezzati Nazhad Dolatabadi, Sajjad Azizi, Ahmad Mobed, Abolghasem Jouyban, Roya Sarkhosh-Inanlou, Michael R. Hamblin, Vahid Shafiei-Irannejad
Publikováno v:
Trends in Analytical Chemistry
There have been many efforts to synthesize advanced materials that are capable of real-time specific recognition of a molecular target, and allow the quantification of a variety of biomolecules. Scaffold materials have a porous structure, with a high
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 132, Iss, Pp 110807-(2020)
Colorectal cancer (CRC) is a stem cell-based disease. PIK3CA/KRAS-mutant CRC stem cells (CRCSCs) display high self-renewal, metastatic properties, high activity of PI3K and KRAS signaling pathways with chemoresistant phenotypes. Recently, RGD peptide